# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
William Blair analyst Max Smock reiterates Catalent (NYSE:CTLT) with a Market Perform.
Conference Call
The expansion increases the site's footprint by 32,000 square feet (3,000 square meters), adding storage and handling of cl...
RBC Capital analyst Sean Dodge reiterates Catalent (NYSE:CTLT) with a Sector Perform and maintains $63.5 price target.
Barclays analyst Luke Sergott maintains Catalent (NYSE:CTLT) with a Equal-Weight and raises the price target from $47 to $63.
Catalent shares rise after Sarepta Therapeutics' Elevidys expanded approval. Despite uncertainties, Catalent's risk/rew...